Apoptosis and Cancer

Add to your list(s) Download to your calendar using vCal

• David Andrews, Vishva Dixit, Gerard Evan, Anthony Letai, Jean Claude Martinou, Pascal Meier, Gerry Melino, Dale Porter, Meike Vogler, Karen Vousden, Domagoj Vucic, Henning Walczak, David Wallach
• Thursday 14 June 2012, 09:00-19:00
• Downing College, Regent Street, Cambridge, UK.

If you have a question about this talk, please contact Lucy Purser.

Meeting website: www.abcam.com/cambridgecancer

A failure of cells to undergo apoptosis is a common feature of many cancers. During the last 20 years, work in many laboratories has led to the identification and understanding of many of the key players involved in apoptosis. This conference will highlight recent developments in our current understanding of the cellular role of some of these proteins as well as how our knowledge of the basic cellular apoptotic pathways is being used to develop targeted cancer chemotherapeutic agents. Particular attention will be paid to novel agents that are currently in development or early clinical trials to exploit our understanding of the Bcl-2 family, the p53 family, death receptors and inhibitor of apoptosis proteins (IAPs). Discussion sessions will involve members from academia as well as industry.

This talk is part of the Abcam meetings series.

This talk is included in these lists:

• Abcam meetings
• Downing College, Regent Street, Cambridge, UK

Note that ex-directory lists are not shown.